Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia

AIM: Phase III, randomized, double‐blind study evaluating the efficacy and safety of ertugliflozin in Asian patients with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin, including evaluation in the China subpopulation. MATERIALS AND METHODS: A 26‐week, double‐blind study of 506...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Ji, Linong, Liu, Yanmei, Miao, Heng, Xie, Yongli, Yang, Ming, Wang, Wei, Mu, Yuting, Yan, Ping, Pan, Sharon, Lauring, Brett, Liu, Shu, Huyck, Susan, Qiu, Yanping, Terra, Steven G.
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379575/
https://ncbi.nlm.nih.gov/pubmed/30830724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13681
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars